BIO-key Projects 50% H1 Revenue Growth to $5M and Profitability
BIO-key forecasts first-half 2026 revenues of $5.0M, a 50% increase over $3.3M in H1’25, driven by a $1.04M software license renewal and over $1M in hardware contracts. The company expects to swing to positive net income and maintain a $2.7M cash balance at June 30, 2026.
1. First-Half 2026 Financial Outlook
BIO-key expects first-half revenues to reach $5.0M, up 50% from $3.3M in the same period last year, and anticipates returning to positive net income after a $1.9M loss in H1’25. The company forecasts ending June 30, 2026, with a cash balance in line with the $2.7M reported at year-end 2025.
2. Q1 and Q2 Revenue Drivers
Q1’26 revenues are projected at $2.2M, marking 37% growth from $1.6M in Q1’25, while Q2’26 revenues are expected to hit $2.8M, a 65% increase over $1.7M. Growth is underpinned by expanded software license momentum and strength in hardware device sales.
3. Key Contracts and Renewals
Performance reflects a $1.04M one-year software license renewal with a longstanding foreign retail bank and over $1M in contracts for Pocket 10 Finger Scanners and Mobile POS Pro devices secured in Q1 and Q2 of 2026. These deals underscore rising customer demand for biometric authentication solutions.
4. Strategic Pipeline and Outlook
Management highlights potential deployments with a foreign tax agency and defense ministry, alongside discussions with new enterprise clients in regulated industries. Disciplined margin and overhead control are expected to translate top-line growth into sustained profitability through the second half of 2026 and into 2027.